Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics

ARWR POWR Grades

• ARWR scores best on the Value dimension, with a Value rank ahead of 66.69% of US stocks.
• The strongest trend for ARWR is in Quality, which has been heading down over the past 179 days.
• ARWR ranks lowest in Momentum; there it ranks in the 12th percentile.

ARWR Stock Summary

• For ARWR, its debt to operating expenses ratio is greater than that reported by merely 12.57% of US equities we're observing.
• With a price/sales ratio of 34.12, Arrowhead Pharmaceuticals Inc has a higher such ratio than 94.93% of stocks in our set.
• Revenue growth over the past 12 months for Arrowhead Pharmaceuticals Inc comes in at 80.89%, a number that bests 89.79% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to Arrowhead Pharmaceuticals Inc, a group of peers worth examining would be ALLO, CGEM, DNLI, ARVN, and BCAB.
• ARWR's SEC filings can be seen here. And to visit Arrowhead Pharmaceuticals Inc's official web site, go to arrowheadpharma.com.

ARWR Valuation Summary

• ARWR's price/earnings ratio is -55.6; this is 252.33% lower than that of the median Healthcare stock.
• ARWR's price/sales ratio has moved NA NA over the prior 209 months.
• Over the past 209 months, ARWR's EV/EBIT ratio has gone NA NA.

Below are key valuation metrics over time for ARWR.

ARWR Growth Metrics

Its 3 year cash and equivalents growth rate is now at 221.34%.
• Its 5 year revenue growth rate is now at 54399.15%.
• Its 2 year net cashflow from operations growth rate is now at 46.17%.

ARWR's revenue has moved up $49,635,454 over the prior 34 months.

The table below shows ARWR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	144.424	148.799	-182.988
2021-09-30	138.287	171.224	-140.848
2021-06-30	107.6379	184.491	-125.9067
2021-03-31	89.12263	180.6738	-109.5939
2020-12-31	79.84049	-110.7831	-102.6115
2020-09-30	87.99207	-95.39157	-84.55323

ARWR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ARWR has a Quality Grade of C, ranking ahead of 55.82% of graded US stocks.
• ARWR's asset turnover comes in at 0.171 -- ranking 211th of 682 Pharmaceutical Products stocks.
• COLL, CRBP, and VBIV are the stocks whose asset turnover ratios are most correlated with ARWR.

The table below shows ARWR's key quality metrics over time.